NO980021L - Rekombinant protein som har bakteriofag endosialidase-enzymatiske aktivitet - Google Patents

Rekombinant protein som har bakteriofag endosialidase-enzymatiske aktivitet

Info

Publication number
NO980021L
NO980021L NO980021A NO980021A NO980021L NO 980021 L NO980021 L NO 980021L NO 980021 A NO980021 A NO 980021A NO 980021 A NO980021 A NO 980021A NO 980021 L NO980021 L NO 980021L
Authority
NO
Norway
Prior art keywords
enzymatic activity
recombinant protein
endosialidase
bacteriophage
protein
Prior art date
Application number
NO980021A
Other languages
English (en)
Other versions
NO980021D0 (no
Inventor
Peter William Taylor
John Paul Luzio
Jonathan Mark Bryant
Original Assignee
Endozyme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endozyme Ltd filed Critical Endozyme Ltd
Publication of NO980021D0 publication Critical patent/NO980021D0/no
Publication of NO980021L publication Critical patent/NO980021L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01129—Endo-alpha-sialidase (3.2.1.129)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Et rekombinant protein som har bakteriofag endosialidase-enzymatisk aktivitet som kan oppnåes ved ekspresjon fra en rekombinant vektor som omfatter en DNA-sekvens som koder for en bakteriofag endosialidase bundet til en DNA-sekvens av en ekspresjonsvektor som uttrykker et polypeptid som tilsettes til N-terminalen av endosialidasen, eller en analog av nevnte protein, som er en mutant, funksjonelt fragment eller derivat av nevnte protein som har endosialidase-enzymatisk aktivitet.
NO980021A 1995-07-05 1998-01-02 Rekombinant protein som har bakteriofag endosialidase-enzymatiske aktivitet NO980021L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513683.4A GB9513683D0 (en) 1995-07-05 1995-07-05 Products
PCT/GB1996/001577 WO1997002351A1 (en) 1995-07-05 1996-07-01 Recombinant protein having bacteriophage endosialidase enzymatic activity

Publications (2)

Publication Number Publication Date
NO980021D0 NO980021D0 (no) 1998-01-02
NO980021L true NO980021L (no) 1998-03-02

Family

ID=10777153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980021A NO980021L (no) 1995-07-05 1998-01-02 Rekombinant protein som har bakteriofag endosialidase-enzymatiske aktivitet

Country Status (14)

Country Link
US (1) US6331425B1 (no)
EP (1) EP0842284A1 (no)
JP (1) JPH11509728A (no)
KR (1) KR19990028642A (no)
CN (1) CN1191572A (no)
AU (1) AU718184B2 (no)
CA (1) CA2226258A1 (no)
CZ (1) CZ421397A3 (no)
GB (1) GB9513683D0 (no)
HU (1) HUP9900323A2 (no)
NO (1) NO980021L (no)
NZ (1) NZ311738A (no)
SK (1) SK1398A3 (no)
WO (1) WO1997002351A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399097B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corporation Composition for treatment of a bacterial infection of the digestive tract
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6399098B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corp Composition for treating dental caries caused by streptococcus mutans
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
DE19856283A1 (de) * 1998-12-07 2000-06-08 Bosch Gmbh Robert Bedämpfungsschaltung für Zweidraht-Bussystem
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US7063837B2 (en) 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US20020187136A1 (en) * 2000-04-28 2002-12-12 Lawrence Loomis Use of bacterial phage associated lysing enzymes for treating various illnesses
US6395504B1 (en) 2000-09-01 2002-05-28 New Horizons Diagnostics Corp. Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7553822B2 (en) * 2003-10-30 2009-06-30 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene
US20050282155A1 (en) * 2004-06-17 2005-12-22 Lucigen Corporation Viral libraries from uncultivated viruses and polypeptides produced therefrom
EP3142692B1 (en) 2014-05-12 2019-05-01 Technion Research & Development Foundation Limited Compositions comprising il-31 and uses thereof
EP3072900A1 (en) * 2015-03-27 2016-09-28 Medizinische Hochschule Hannover Anti-tumour medicament based on adenovirus
CN106906236B (zh) * 2017-04-10 2020-04-10 中国科学院深海科学与工程研究所 唾液酸酶基因重组表达载体及其构建方法，唾液酸酶及其制备方法
US10174295B1 (en) * 2017-08-01 2019-01-08 The Charles Stark Draper Laboratory, Inc. Composition of matter: engineering of Escherichia coli phage K1E
CN112522236A (zh) * 2020-12-23 2021-03-19 南京农业大学 一种针对k1荚膜大肠杆菌的噬菌体内切唾液酸酶及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695541A (en) 1985-01-31 1987-09-22 Molecular Diagnostics, Inc. Enzymatic detection of bacterial capsular polysaccharide antigens
US5654176A (en) * 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
GB9120221D0 (en) * 1991-09-23 1991-11-06 Smithkline Beecham Biolog Novel compounds
GB9210337D0 (en) * 1992-05-14 1992-07-01 Univ Court Of The University O Feline leukaemia virus vaccine
IT1262981B (it) 1992-09-09 1996-07-23 Tecnogen Scpa Procedimento per la purificazione della proteina big endotelina
WO1994025061A1 (en) * 1993-04-23 1994-11-10 Glyko, Inc. Methods and compositions for treating diseases with carbohydrate modifying enzymes
US6303369B1 (en) * 1993-09-30 2001-10-16 Carl Spana Protein expression system

Also Published As

Publication number Publication date
NZ311738A (en) 2001-05-25
WO1997002351A1 (en) 1997-01-23
CN1191572A (zh) 1998-08-26
KR19990028642A (ko) 1999-04-15
US6331425B1 (en) 2001-12-18
JPH11509728A (ja) 1999-08-31
CA2226258A1 (en) 1997-01-23
CZ421397A3 (cs) 1998-04-15
EP0842284A1 (en) 1998-05-20
GB9513683D0 (en) 1995-09-06
AU6311696A (en) 1997-02-05
HUP9900323A2 (hu) 1999-05-28
MX9800097A (es) 1998-08-30
SK1398A3 (en) 2000-05-16
AU718184B2 (en) 2000-04-06
NO980021D0 (no) 1998-01-02

Similar Documents

Publication Publication Date Title
NO980021L (no) Rekombinant protein som har bakteriofag endosialidase-enzymatiske aktivitet
AU1672388A (en) Expression of human proapolipoprotein a-i
ATE332378T1 (de) Polypeptide mit phytase wirkung
EP1651166B8 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
DK1129190T3 (da) Human TSLP DNA og polypeptider
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
BR0317537A (pt) Processo para preparar aminoácidos em organismos transgênicos, construção de ácido nucleico, vetor, organismo procariótico ou eucariótico transgênico, uso dos organismos transgênicos, e, sequencia de aminoácidos
NO970113D0 (no) Kollagenbindende protein eller polypeptid
WO2001088114A3 (en) Gene expression system
FI913434A7 (fi) Rekombinanta fusionsproteiner vilka utsoendras.
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
DE69023284D1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
NO20021851L (no) <Beta>-barrel av lipidstofflipoksygenase
DE69528575D1 (de) Antifungale proteine, dafür kodierende dna, und diese enthaltende wirtzelle
NO981220L (no) Cytokrom c samt gen for dette
KR970065711A (ko) 터닙 모자이크 바이러스 c5로부터 분리한 프로테아제
NO910981L (no) Peptidforbindelser.
MX9605938A (es) Promotor de actinomicetos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application